Predictive Significance of Plasma Levels of Interleukin-6 and High-Sensitivity C-Reactive Protein in Atrial Fibrillation after Coronary Artery Bypass Surgery
DOI:
https://doi.org/10.1532/HSF98.20061175Abstract
Background. Postoperative atrial fibrillation (AF) plays a major role in the determination of hemodynamic deterioration and can be associated with cardiovascular events after coronary artery surgery. Elevated interleukin (IL)-6 and Creactive protein (CRP) levels in patients with AF suggest a role of inflammation in the pathogenesis of AF. We conducted a study to investigate the correlation between postoperative AF and IL-6 and high-sensitivity CRP (hsCRP).
Materials and Methods. Forty-nine patients with a mean age of 60.3 ± 10.7 years were enrolled in this study. Preoperative and postoperative first day blood samples were collected to assess the IL-6 and hsCRP levels. IL-6 levels were measured by enzyme-linked immunosorbent assay, and hsCRP was measured by rate turbidimetry method.
Results. Fourteen patients (28.5%) developed AF postoperatively. Patients who developed AF showed elevated serum concentrations of postoperative first day IL-6 (P < .001), preoperative hsCRP (P < .005), and postoperative first day hsCRP (P < 0.001). Preoperative hsCRP levels (P < .002) and postoperative first day IL-6 (P < .001) and hsCRP (P < 0.001) levels were associated with prolonged endotracheal intubation time. Prolonged intensive care unit stay showed significant correlations with elevated levels of preoperative hsCRP (P < 0.002) and postoperative first day IL-6 (P < 0.001) and hsCRP (P < 0.001). There was also statistical significance between the AF+ and AF- groups regarding intensive care unit stay and endotracheal intubation times (P < .001 and P < .001, respectively). Cut-off points for postoperative first day IL-6, preoperative hsCRP, and postoperative first day hsCRP were 46.4 pg/mL (sensitivity = 92.9% and specificity = 80%), 0.46 mg/L (sensitivity = 71% and specificity = 75%), and 17.9 mg/L (sensitivity = 92.9% and specificity = 78%), respectively.
Conclusions. Elevated IL-6 and hsCRP levels in patients with postoperative AF suggest inflammatory components have a role of in the pathogenesis of AF.
References
Aviles RJ, Martin DO, Apperson-Hansen C, et al. 2003. Inflammation as a risk factor for atrial fibrillation. Circulation 108: 3006-10.nAlmassi GH, Schowalter T, Nicolosi AC, et al. 1997. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 226:501-11.nAranki SF, Shaw DP, Adams DH, et al. 1996. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 94:390-7.nBruins P, Velthuis H, Yazdanbakhsh AP, et al. 1997. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96:3542-8.nChamoro A. 2004. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004;17:1-5.nChung MK, Martin DO, Sprecher D, et al. 2001. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 199:2886-91.nConway DS, Buggins P, Hughe E, Lip GY. 2004. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148:462-6.nCremer J, Martin M, Redl H, et al. 1996. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 61:1714-20.nCrosby LH, Pifalo WB, Woll KR, Burkholder JA. 1990. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 66:1520-2.nCzerny M, Baumer H, Kilo J, et al. 2000. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17:737-42.nDaoud EG, Strickberger SA, Man KC, et al. 1997. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337:1785-91.nDavies MJ, Pomerance A. 1972. Pathology of atrial fibrillation in man. Br Heart J 34:520-5.nDernellis J, Panaretou M. 2004. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25:1100-7.nDucceschi V, D'Andrea A, Liccardo B, et al. 1999. Perioperative clinical predictors of atrial fibrillation occurrence following coronary artery surgery. Eur J Cardiothorac Surg 16:435-9.nFrustaci A, Cristina C, Fulvio B, Emanuela M, Matteo A, Attilio M. 1997. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180-4.nGaudino M, Andreotti F, Zamparelli R, et al. 2003. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108:195-9.nGaudino M, Nasso G, Andreotti F, et al. 2002. Preoperative C-reactive protein level and outcome following coronary surgery. Eur J Cardiothorac Surg 22:521-6.nGu YJ, Mariani MA, van Oeveren W, Grandjean JG, Boonstra PW. 1998. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 65:420-4.nHogue CW, Murphy SF, Schechtman KB, Davila-Roman VG. 1999. Risk factors for early or delayed stroke after cardiac surgery. Circulation 100:642-7.nKerr R, Stirling D, Ludlam CA. 2001. Interleukin 6 and haemostasis. Br J Hematol 115:3-12.nLip GY, Lowe GD, Rumley A, Dunn FG. 1995. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 73:527-33.nMendes LA, Connelly GP, McKenney PA, et al. 1995. Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol 25:198-202.nMoulton MJ, Creswell LL, Machery ME, Cox JL, Rosenbloom M. 1996. Reexploration for bleeding is a risk factor for adverse outcome after cardiac operations. J Thorac Cardiovasc Surg 111:1037-46.nPsychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. 2005. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95:764-7.nRoldan V, Marin F, Blann AD, et al. 2003. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24:1373-80.nRubens FD, Nathan H, Labow R, et al. 2005. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 79:655-65.nSata N, Hamada N, Horinouchi T, et al. 2004. C-reactive protein and atrial fibrillation: is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 45:441-5.nSawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H. 1998. Interleukin-6 derived from hypoxic myocytes promotes neutrophilmediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116:511-7.nStamou SC, Dangas G, Hill PC, et al. 2000. Atrial fibrillation after beating heart surgery. Am J Cardiol 86:64-7.nTaylor K. 1996. SIRS: the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61:1607-8.nWan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. 1996. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112:806-11.n
